• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

$8.9M collaborative grant to understand how dangerous virus ‘hides’ to attack another…

Bioengineer.org by Bioengineer.org
January 23, 2018
in Headlines, Health, Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Jason Ryder

The University of Arizona's Felicia Goodrum, PhD, and some of the nation's most prominent human cytomegalovirus researchers have been awarded a five-year, $8.9 million collaborative grant to investigate how the virus lies dormant until it activates and poses life-threatening disease risk.

Dr. Goodrum, working with investigators at Louisiana State University Health Sciences Center in Shreveport and the lead organization, Oregon Health & Science University, will investigate different aspects of the virus-host interaction of the human cytomegalovirus (HCMV), one of nine human herpesviruses.

HCMV is a member of the herpesvirus family. Unlike many virus infections, HCMV infections are chronic – they never are cleared by the host. Instead, they hide their presence in dormancy. More than half of adults by age 40 have been infected with HCMV and most show no signs or symptoms. When HCMV is reactivated from dormancy, it poses life-threatening disease risks in individuals with compromised immune systems, including transplant, AIDS and cancer patients. HCMV infection also is the leading cause of infectious disease-related birth defects, affecting 1 in 150 live births in the United States.

Dr. Goodrum is an associate professor at the UA College of Medicine – Tucson, Department of Immunobiology, and a member of the UA BIO5 Institute. She will receive $1.3 million over five years. The grant, No. 1PO1Al127335-01, is funded by the National Institute of Allergy and Infectious Diseases.

"The University of Arizona's involvement in this collaborative effort is an outstanding example of the importance of basic science research and the role it plays in improving lives," said UA President Robert C. Robbins. "Dr. Goodrum has already had incredible impact in the biomedical sciences, and I look forward to learning the outcomes of this newest investigation."

Dr. Goodrum said each of the research teams will look at a different aspect of the virus-host interaction to understand how the virus "hijacks," or manipulates, signaling pathways, the way cells communicate with one another, within its host, regulating how a host cell receives and transmits information from outside the cell's environment to sense and respond to infection.

Their aim is to understand how HCMV can hijack its host's biology allowing it to control entry and exit from dormant and active cycles, a key to its ability to exist in the human host.

Nationally renowned for her research on the virus, Dr. Goodrum was the first to discover the viral proteins that function to mediate the switch between dormant and actively replicative states. For this grant, Dr. Goodrum will seek to determine how proteins communicate with other "viral microRNAs" and proteins identified by the other project leaders to target the same host signaling pathways. Viral microRNAs are small nucleic acids that silence host gene expression, affecting virus infection by regulating virus or host gene expression to avoid the host defenses and/or to maintain latent and persistent infection.

"Understanding the virus-host interaction will represent a major step forward in understanding how we might target the dormant infection. No vaccine exists for the virus and current antivirals only target cells actively replicating the virus, so the virus is able to persist in dormancy," said Dr. Goodrum.

###

Project leaders at OHSU are Jay Nelson, PhD, Dan Streblow, PhD, and Patrizia Caposio, PhD; Andrew Yurochko, PhD, is the project leader at Louisiana State University Health Sciences Center in Shreveport.

For related research please see: http://opa.uahs.arizona.edu/newsroom/news/2018/ua-researchers-create-first-roadmap-understand-ability-herpesvirus-remain-dormant

About the University of Arizona Health Sciences

The University of Arizona Health Sciences is the statewide leader in biomedical research and health professions training. The UA Health Sciences includes the UA Colleges of Medicine (Phoenix and Tucson), Nursing, Pharmacy and Mel and Enid Zuckerman College of Public Health, with main campus locations in Tucson and the growing Phoenix Biomedical Campus in downtown Phoenix. From these vantage points, the UA Health Sciences reaches across the state of Arizona and the greater Southwest to provide cutting-edge health education, research, patient care and community outreach services. A major economic engine, the UA Health Sciences employs almost 5,000 people, has nearly 1,000 faculty members and garners more than $126 million in research grants and contracts annually. For more information: uahs.arizona.edu.

Media Contact

Rebecca Ruiz Hudman
[email protected]
520-626-8434

http://uahs.arizona.edu/

Original Source

http://opa.uahs.arizona.edu/newsroom/news/2018/ua-part-89m-collaborative-grant-understand-how-dangerous-virus-hides-attack

Share12Tweet7Share2ShareShareShare1

Related Posts

Boosting Xanthan Gum Production with Essential Oil By-products

Boosting Xanthan Gum Production with Essential Oil By-products

September 13, 2025
Groundwater Pesticide Contamination: Challenges and Solutions

Groundwater Pesticide Contamination: Challenges and Solutions

September 13, 2025

FBXW11 Ubiquitinates YB1, Suppressing Hepatocarcinoma Growth

September 13, 2025

Interpretable Deep Learning for Anticancer Peptide Prediction

September 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Boosting Xanthan Gum Production with Essential Oil By-products

Groundwater Pesticide Contamination: Challenges and Solutions

FBXW11 Ubiquitinates YB1, Suppressing Hepatocarcinoma Growth

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.